Recent studies have already shown that kinase inhibition can alleviate mitochondrial dysfunction in mouse models of mitochondrial disease by dampening mTOR, PKC, or AMPK signaling (51, 52, 53). The gene discussed is PRRT2; the disease is inborn mitochondrial metabolism disorder.